Sernova (TSE:SVA) Reaches New 12-Month Low – What’s Next?

Sernova Corp. (TSE:SVA)’s stock price reached a new 52-week low during trading on Friday . The stock traded as low as C$0.21 and last traded at C$0.22, with a volume of 196750 shares changing hands. The stock had previously closed at C$0.22.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Ventum Cap Mkts raised shares of Sernova to a “strong-buy” rating in a report on Thursday, September 12th. Ventum Financial dropped their target price on shares of Sernova from C$3.00 to C$2.50 and set a “buy” rating on the stock in a research report on Friday, September 13th. Finally, Leede Financial decreased their price target on shares of Sernova from C$3.00 to C$1.50 and set a “speculative buy” rating for the company in a report on Friday, September 13th.

Sernova Stock Performance

The firm has a 50 day moving average price of C$0.24 and a 200-day moving average price of C$0.26. The stock has a market capitalization of C$69.94 million, a PE ratio of -1.65 and a beta of 1.35. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of 16.55.

Sernova Company Profile

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.